HIV - Monotherapy Label Expansion From Webinar
Post# of 148183
(Total Views: 500)
Posted On: 03/20/2020 12:24:39 AM
HIV - Monotherapy Label Expansion
From Webinar 3/19/2020
Deal talks in Japan, Taiwan and China are still ongoing. They are focusing on COVID-19 in the United States. COVID-19 results in the U.S. will strengthen their bargaining positions elsewhere.
From Webinar 3/19/2020
Quote:
03:48 Nader Pourhassan - Monotherapy was the first time that the single agent antibody that was self-injectable at home was tested and the results got better and better where the FDA agreed to look at a pivotal clinical trial and consider that for final approval after the first approval so it will be expanded label.
Deal talks in Japan, Taiwan and China are still ongoing. They are focusing on COVID-19 in the United States. COVID-19 results in the U.S. will strengthen their bargaining positions elsewhere.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼